24 results
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access … , as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.
(pp) Compliance with Data Privacy Laws
8-K
EX-1.1
HEPA
Hepion Pharmaceuticals Inc
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
(collectively, “HIPAA”); (v) any “personal information” as defined by the California Consumer Privacy Act (“CCPA”); and (vi) any other piece … obligations relating to the privacy and security of IT Systems, Confidential Data, and Personal Data and to the protection of such IT Systems, Confidential
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm
relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access
8-K
EX-1.1
kx2vmfr5o04y82f3m
12 Feb 20
Entry into a Material Definitive Agreement
4:55pm
10-KT
enqzf4y2w9q6j x5hl
26 Mar 18
Annual report (with FYE transition)
12:00am
424B5
gtoj1yeg2 a4
7 Oct 15
Prospectus supplement for primary offering
12:00am
10-K
yg6mm6m6g15zc3
29 Sep 14
Annual report
12:00am
10-12G/A
EX-99.1
xxi4dct ano
6 Feb 14
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
we5qhg 71vdkix4t549
24 Dec 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
unhjtof8
21 Nov 13
Registration of securities (amended)
12:00am